Calls BPC-157 "the Wild West" promising but no human RCTs 39% lean mass loss concern from STEP 1 trial advocates resistance training + high protein alongside GLP-1 Clinical prescribing perspective on GLP-1 agonists Protocols shown here are based on publicly disclosed information from Peter Attia
Indocyanine green-based fluorescence guidance has been commonly used to demarcate HCC lesion boundaries, but it cannot distinguish between benign and malignant liver tumors
Carullo G, Federico S, Relitti N et al (2020) Retinitis pigmentosa and retinal degenerations: deciphering pathways and targets for drug discovery and development
NAD+ levels decline approximately 50% between ages 40 and 60, which correlates with increased systemic inflammation (often called "inflammaging")
On many insulin syringes, 5 units is the smallest clearly marked increment
This comprehensive training programme covers both theory and practical application, ensuring you leave with the confidence to safely perform treatments